» Articles » PMID: 37441959

Electronic Harm Reduction Interventions for Drug Overdose Monitoring and Prevention: A Scoping Review

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2023 Jul 13
PMID 37441959
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Novel strategies are required to address rising overdose deaths across the globe. We sought to identify the breadth and depth of the existing evidence around electronic harm reduction (e-harm reduction) interventions that aimed to reduce the harms associated with substance use.

Methods: We conducted a scoping review according to the PRISMA-ScR and PRISMA for Searching guidelines. A health sciences librarian systematically searched seven health databases from inception until January 20, 2023. Citation chaining and reference lists of included studies were searched to identify additional articles. Two reviewers independently screened, extracted and charted the data. Additionally, we conducted a gray literature search and environmental scan to supplement the findings.

Results: A total of 51 studies met the criteria for inclusion (30 peer-reviewed articles and 21 non-peer reviewed). Most peer-reviewed studies were conducted in Western countries (USA = 23, Canada = 3, Europe = 3, China = 1) and among adult samples (adult = 27, youth/adults =1, unspecified = 2). Study designs were predominantly quantitative (n = 24), with a minority using qualitative (n = 4) or mixed methods (n = 2). Most e-harm reduction interventions were harm reduction (n = 15), followed by education (n = 6), treatment (n = 2), and combined/other approaches (n = 7). Interventions utilized web-based/mobile applications (n = 15), telephone/telehealth (n = 10), and other technology (n = 5).

Conclusions: While e-harm reduction technology is promising, further research is required to establish the efficacy and effectiveness of these novel interventions.

Citing Articles

Feasibility and acceptability of multiple methods of recording injecting drug use episode data among people who inject drugs in Melbourne, Australia: a pilot evaluation study protocol.

Djordjevic F, Stewart A, Vella-Horne D, Gleeson Z, Pavlyshyn D, Gill M BMJ Open. 2025; 14(12):e091613.

PMID: 39806692 PMC: 11667416. DOI: 10.1136/bmjopen-2024-091613.


Perceptions of overdose response hotlines and applications among rural and remote individuals who use drugs in Canada: a qualitative study.

Viste D, Rioux W, Medwid M, Williams K, Tailfeathers E, Lee A Health Promot Chronic Dis Prev Can. 2024; 44(11-12):471-481.

PMID: 39607434 PMC: 11728862. DOI: 10.24095/hpcdp.44.11/12.03.


Perspectives of key interest groups regarding supervised Consumption sites (SCS) and novel virtual harm reduction services / overdose response hotlines and applications: a qualitative Canadian study.

Seo B, Rioux W, Teare A, Rider N, Jones S, Taplay P Harm Reduct J. 2024; 21(1):141.

PMID: 39068494 PMC: 11282589. DOI: 10.1186/s12954-024-01053-3.


Implementing Canada's first national virtual phone based overdose prevention service: lessons learned from creating the National Overdose Response Service (NORS).

Rioux W, Taplay P, Morris-Miller L, Ghosh S Harm Reduct J. 2024; 21(1):102.

PMID: 38807227 PMC: 11131261. DOI: 10.1186/s12954-024-01017-7.


Perceptions of Overdose Response Hotlines and Phone Application Services Among Women and Gender-diverse Individuals Who Use Drugs in Canada: A Qualitative Study.

Lee A, Jafri F, Viste D, Seo B, Skiber D, Medwid M J Addict Med. 2024; 18(5):553-560.

PMID: 38785357 PMC: 11882170. DOI: 10.1097/ADM.0000000000001325.